JP2023553490A5 - - Google Patents
Info
- Publication number
- JP2023553490A5 JP2023553490A5 JP2023536049A JP2023536049A JP2023553490A5 JP 2023553490 A5 JP2023553490 A5 JP 2023553490A5 JP 2023536049 A JP2023536049 A JP 2023536049A JP 2023536049 A JP2023536049 A JP 2023536049A JP 2023553490 A5 JP2023553490 A5 JP 2023553490A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063125833P | 2020-12-15 | 2020-12-15 | |
| US63/125,833 | 2020-12-15 | ||
| US202163137097P | 2021-01-13 | 2021-01-13 | |
| US63/137,097 | 2021-01-13 | ||
| US202163212991P | 2021-06-21 | 2021-06-21 | |
| US63/212,991 | 2021-06-21 | ||
| US202163281022P | 2021-11-18 | 2021-11-18 | |
| US63/281,022 | 2021-11-18 | ||
| PCT/US2021/010059 WO2022132195A2 (en) | 2020-12-15 | 2021-12-15 | Compositions and methods for modulation myc expression |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023553490A JP2023553490A (ja) | 2023-12-21 |
| JP2023553490A5 true JP2023553490A5 (https=) | 2024-12-23 |
| JPWO2022132195A5 JPWO2022132195A5 (https=) | 2024-12-23 |
Family
ID=82060102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023536049A Pending JP2023553490A (ja) | 2020-12-15 | 2021-12-15 | Ｍｙｃ発現を調節するための組成物及び方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240132559A1 (https=) |
| EP (1) | EP4262849A4 (https=) |
| JP (1) | JP2023553490A (https=) |
| KR (1) | KR20230120138A (https=) |
| AU (1) | AU2021401231A1 (https=) |
| CA (1) | CA3205133A1 (https=) |
| MX (1) | MX2023007116A (https=) |
| WO (1) | WO2022132195A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7682604B2 (ja) | 2016-09-07 | 2025-05-26 | フラッグシップ パイオニアリング イノベーションズ ブイ， インコーポレイテッド | 遺伝子発現をモジュレートするための方法および組成物 |
| CN115192714B (zh) * | 2022-07-08 | 2024-09-17 | 沈阳药科大学 | Hdac6抑制剂在制备治疗dnmt3a基因缺失癌症的药物中的用途 |
| TW202417012A (zh) * | 2022-08-19 | 2024-05-01 | 美商旗艦先鋒創新公司 | 包含myc調節劑及檢查點抑制劑之組合療法 |
| WO2024238723A1 (en) | 2023-05-16 | 2024-11-21 | Omega Therapeutics, Inc. | Methods and compositions for modulating pcsk9 expression |
| WO2024238726A1 (en) | 2023-05-16 | 2024-11-21 | Omega Therapeutics, Inc. | Methods and compositions for modulating methylation of a target gene |
| WO2024243438A2 (en) * | 2023-05-23 | 2024-11-28 | Omega Therapeutics, Inc. | Compositions and methods for reducing cxcl9, cxcl10, and cxcl11 gene expression |
| WO2025019742A1 (en) | 2023-07-19 | 2025-01-23 | Omega Therapeutics, Inc. | Methods and compositions for modulating ctnnb1 expression |
| WO2025064469A1 (en) * | 2023-09-18 | 2025-03-27 | Omega Therapeutics, Inc. | Methods for assessing dosage for epigenetic modifying agents |
| WO2025144907A1 (en) * | 2023-12-27 | 2025-07-03 | Flagship Pioneering Innovations V, Inc. | Kinase inhibitors and particles comprising myc modulators |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997011972A1 (en) * | 1995-09-28 | 1997-04-03 | The Trustees Of Columbia University In The City Of New York | Chimeric dna-binding/dna methyltransferase nucleic acid and polypeptide and uses thereof |
| GB201119904D0 (en) * | 2011-11-17 | 2011-12-28 | Univ Vilnius | Analysis of methylation sites |
| US20170369855A1 (en) * | 2014-12-24 | 2017-12-28 | Dana-Farber Cancer Institute, Inc. | Systems and methods for genome modification and regulation |
| KR101900278B1 (ko) * | 2016-04-18 | 2018-09-19 | 건국대학교 글로컬산학협력단 | Myc-ap4 축 활성화된 암의 예방 또는 치료용 조성물의 스크리닝 방법 |
| WO2018111944A1 (en) * | 2016-12-12 | 2018-06-21 | Whitehead Institute For Biomedical Research | Regulation of transcription through ctcf loop anchors |
| JP2020515258A (ja) * | 2017-03-31 | 2020-05-28 | アジェノビア コーポレーション | 抗ウイルス治療剤 |
| US20190233805A1 (en) * | 2017-10-04 | 2019-08-01 | The Regents Of The University Of California | Targetable proteins for epigenetic modification and methods for use thereof |
| US20220380760A1 (en) * | 2018-10-15 | 2022-12-01 | Flagship Pioneering Innovations V, Inc. | Disrupting genomic complex assembly in fusion genes |
| US11866469B2 (en) * | 2019-02-06 | 2024-01-09 | Klogenix Llc | DNA binding proteins and uses thereof |
-
2021
- 2021-12-15 KR KR1020237024060A patent/KR20230120138A/ko active Pending
- 2021-12-15 MX MX2023007116A patent/MX2023007116A/es unknown
- 2021-12-15 EP EP21907332.7A patent/EP4262849A4/en active Pending
- 2021-12-15 US US18/257,483 patent/US20240132559A1/en active Pending
- 2021-12-15 CA CA3205133A patent/CA3205133A1/en active Pending
- 2021-12-15 JP JP2023536049A patent/JP2023553490A/ja active Pending
- 2021-12-15 AU AU2021401231A patent/AU2021401231A1/en active Pending
- 2021-12-15 WO PCT/US2021/010059 patent/WO2022132195A2/en not_active Ceased